Gainers & Losers
Mon Nov 25 2024 08:06:29- Larsen & Toubro share price
- ₹3,749.454.02%
- State Bank Of India share price
- ₹846.203.69%
- Reliance Industries share price
- ₹1,292.152.07%
- ICICI Bank share price
- ₹1,304.152.03%
- NTPC share price
- ₹372.501.86%
Active Stocks
Mon Nov 25 2024 08:06:42- Power Grid Corporation Of ...
- ₹339.400.71%
- Adani Power share price
- ₹460.900.03%
- Tata Steel share price
- ₹144.801.40%
- State Bank Of India share price
- ₹846.203.69%
- Bharat Electronics share price
- ₹294.154.75%
Business News/Market/Market Stats/IPCA Laboratories share price/ IPCA Laboratories Profit Loss Annual
IPCA Laboratories Profit & Loss Annual
Trade1,619.85 +29.30 (1.84%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 7,705.04 | 6,244.32 | 5,829.79 | 5,419.99 |
| Total Revenue | 7,705.04 | 6,244.32 | 5,829.79 | 5,419.99 |
| Costof Revenue Total | 2,575.75 | 2,731.31 | 2,381.14 | 2,033.91 |
| Gross Profit | 5,129.29 | 3,513.01 | 3,448.65 | 3,386.08 |
| Selling/ General/ Admin Expenses Total | 1,708.43 | 2,474.11 | 2,092.32 | 1,788.86 |
| Depreciation/ Amortization | 357.24 | 261.56 | 232.42 | 209.17 |
| Unusual Expense( Income) | 175.76 | 0.00 | 0.00 | 18.33 |
| Other Operating Expenses Total | 2,099.70 | 31.65 | 23.76 | 19.79 |
| Total Operating Expense | 6,916.88 | 5,544.76 | 4,771.44 | 4,122.44 |
| Operating Income | 788.16 | 699.56 | 1,058.35 | 1,297.55 |
| Interest Inc( Exp) Net- Non- Op Total | -734.90 | 201.00 | 530.30 | 735.60 |
| Gain( Loss)on Saleof Assets | 32.30 | 132.10 | -113.90 | -28.60 |
| Other Net | 124.77 | 12.42 | 14.57 | 13.03 |
| Net Income Before Taxes | 842.67 | 745.29 | 1,114.56 | 1,381.28 |
| Provisionfor Income Taxes | 313.46 | 253.36 | 224.77 | 240.14 |
| Net Income After Taxes | 529.21 | 491.93 | 889.79 | 1,141.14 |
| Minority Interest | 24.43 | -7.67 | -5.71 | -1.13 |
| Equity In Affiliates | -62.90 | -129.40 | - | - |
| Net Income Before Extra Items | 547.35 | 471.32 | 884.08 | 1,140.01 |
| Net Income | 547.35 | 471.32 | 884.08 | 1,140.01 |
| Income Availableto Com Excl Extra Ord | 547.35 | 471.32 | 884.08 | 1,140.01 |
| Income Availableto Com Incl Extra Ord | 547.35 | 471.32 | 884.08 | 1,140.01 |
| Diluted Net Income | 547.35 | 471.32 | 884.08 | 1,140.01 |
| Diluted Weighted Average Shares | 25.38 | 25.37 | 25.37 | 25.33 |
| Diluted EPS Excluding Extra Ord Items | 21.57 | 18.58 | 34.85 | 45.01 |
| DPS- Common Stock Primary Issue | 4.00 | 4.00 | 4.00 | 4.00 |
| Diluted Normalized EPS | 25.84 | 18.23 | 35.21 | 45.70 |
| Research Development | - | 461.30 | 418.00 | 523.80 |
*All figures in crores except per share values
IPCA Laboratories Quick Links
IPCA Laboratories Dividend IPCA Laboratories Bonus IPCA Laboratories News IPCA Laboratories AGM IPCA Laboratories Rights IPCA Laboratories Splits IPCA Laboratories Board Meetings IPCA Laboratories Key Metrics IPCA Laboratories Shareholdings IPCA Laboratories Balance Sheet IPCA Laboratories Cashflow IPCA Laboratories Q1 Results IPCA Laboratories Q2 Results IPCA Laboratories Q3 Results IPCA Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,752.90+148.35(4.12%)
846.60+30.55(3.74%)
1,292.25+26.30(2.08%)
1,888.15-14.80 (-0.78%)
1,886.95-12.10 (-0.64%)